Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Cancer Research|January 20, 2007
O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cellsMichael D Blough, Magdalena C Zlatescu, J Gregory CairncrossCell Cycle (Georgetown, Tex.)|August 23, 2008
p53 Binding to the p21 promoter is dependent on the nature of DNA damageRichard Hill, Ewelina Bodzak, Michael D Blough, et al.Journal of Neuro-Oncology|July 2, 2010
Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastomaMichael D Blough, Desiree C Beauchamp, Morgan R Westgate, et al.Neuro-Oncology|April 15, 2010
Sensitivity to temozolomide in brain tumor initiating cellsMichael D Blough, Morgan R Westgate, Desiree Beauchamp, et al.Neuro-Oncology|December 25, 2012
On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cellsOwen D Stechishin, H Artee Luchman, Yibing Ruan, et al.Neuro-Oncology|August 7, 2015
Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumorsBrad Davis, Yaoqing Shen, Candice C Poon, et al.Neuroimage. Clinical|July 21, 2016
Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoringMyriam M Chaumeil, Marina Radoul, Chloé Najac, et al.Journal of Neuro-Oncology|June 21, 2020
PARP inhibition suppresses the emergence of temozolomide resistance in a model systemAlice L Yuan, Mathieu Meode, Melanie Tan, et al.Neuro-Oncology|December 25, 2013
Lactate dehydrogenase A silencing in IDH mutant gliomasCharles Chesnelong, Myriam M Chaumeil, Michael D Blough, et al.Neuro-Oncology|December 15, 2011
An in vivo patient-derived model of endogenous IDH1-mutant gliomaH Artee Luchman, Owen D Stechishin, N Ha Dang, et al.Pageof 3